Protein Kinase C Theta (PKCθ) Regulates KIT Expression and Proliferation in Gastrointestinal Stromal Tumors

Oncogenic KIT or PDGFRA receptor tyrosine kinase mutations are compelling therapeutic targets in gastrointestinal stromal tumors (GISTs), and the KIT/PDGFRA kinase inhibitor, imatinib, is standard of care for patients with metastatic GIST. However, most of these patients eventually develop clinical...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ou, Wen-bin, Zhu, Mei-jun, Demetri, George D., Fletcher, Christopher DM, Fletcher, Jonathan A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2811224/
https://ncbi.nlm.nih.gov/pubmed/18521081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2008.177
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky